作者: Abir Salwa Ali , Malin Grönberg , Birgitte Federspiel , Jean-Yves Scoazec , Geir Olav Hjortland
DOI: 10.1371/JOURNAL.PONE.0187667
关键词: Cancer 、 P53 protein 、 Internal medicine 、 Neuroendocrine carcinoma 、 Neuroendocrine Carcinomas 、 Oncology 、 Chemotherapy 、 Medicine 、 Pancreas
摘要: Background Gastroenteropancreatic neuroendocrine carcinomas (GEP-NECs) are aggressive, rapidly proliferating tumors. Therapeutic response to current chemotherapy regimens is usually short lasting. ...